How to make early drug development planning your biggest flex ??
When it comes to drug development, the early bird definitely gets the worm. Early planning is the best way to de-risk the scientific, regulatory, and commercial hurdles your investigational drug needs to clear. Good thing that Certara has your back! In this issue of the Inner Circle newsletter, we’re sharing blogs, webinars, and articles that are chock full of pro tips on how to maximize your program’s likelihood of success by leveraging our tech-enabled products and consulting. Happy reading!
ON-DEMAND WEBINAR: FDA Modernization Act 2.0 – What does it mean for drug developers?
BLOG: How the Simcyp Discovery Simulator will Accelerate Early Drug Development
ARTICLE: The Case for Market Access...Early and Often
领英推荐
DATA INFORMATICS: Access and visualize nonclinical data for confident decisions with the SEND Explorer Product Family
WHITE PAPER: Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program
Register now to attend live scientific webinars
Where to find Certara this?Spring
Enjoying the?Inner?Circle? Don't forget to?subscribe?at the top or bottom.??
Want to share? Click share below.
Have questions about our services and software??Contact us .
About Certara
Certara ?accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
Corporate Headquarters: 100 Overlook Center, Suite 101, Princeton, NJ 08540 USA